%0 Controlled Clinical Trial
%T Compound betamethasone in the treatment of pain after supraspinatus tendon repair.
%A Da H
%A Song JK
%A Liu L
%A Zhou L
%A Da H
%A Song JK
%A Liu L
%A Zhou L
%A Da H
%A Song JK
%A Liu L
%A Zhou L
%J J Int Med Res
%V 50
%N 9
%D Sep 2022
%M 36113007
%F 1.573
%R 10.1177/03000605221121962
%X <B>OBJECTIVE: </B>To investigate the effect of compound betamethasone on pain points of the supraspinatus tendon by local blocking therapy after repair surgery.<BR><B>METHODS: </B>This non-randomised controlled trial included patients who underwent arthroscopic repair of supraspinatus tendon tears and who had long-term pain. At 3 months following surgery, patients were assigned to an experimental group, whose pain points were treated with compound betamethasone, or a control group who did not receive compound betamethasone. Visual analogue scale (VAS) score, Pittsburgh Sleep Quality Index (PSQI) and Constant shoulder score for pain were determined at 3, 4, 5 and 6 months following surgery and analysed retrospectively.<BR><B>RESULTS: </B>Of 38 included patients, there were no statistically significant between-group differences in VAS score, PSQI or Constant shoulder scores at 3 months following surgery. At 4, 5 and 6 months after surgery, the VAS score and PSQI were significantly lower, and the Constant shoulder score was significantly higher, in the experimental group versus controls.<BR><B>CONCLUSIONS: </B>Using compound betamethasone to locally block pain points after supraspinatus tendon repair surgery may significantly alleviate pain, improve sleep quality, facilitate functional shoulder exercise and achieve good shoulder function.